Table 2.
Clinical Characteristics
| Normal (N=55) | Mildly Impaired (N=109) | Moderately Impaired (N=170) | Significance | Entire Sample (N=334) | |
|---|---|---|---|---|---|
| Days Post Stroke | 8.0 ± 6.6 | 9.2 ± 8.7 | 10.7 ± 10.8 | NS (p=.13) | 9.8 ± 9.6 |
| Lesion Side (N [%]) | |||||
| Right | 26 (47%) | 56 (51%) | 87 (51%) | NS (p=.93) | 169 (50%) |
| Left | 25 (46%) | 43 (40%) | 71 (42%) | 139 (42%) | |
| Bilateral | 4 (7%) | 10 (9%) | 12 (7%) | 26 (8%) | |
| Stroke Type (N [%]) | |||||
| Ischemic | 50 (91%) | 101 (93%) | 156 (92%) | NS (p=.92) | 307 (92%) |
| Hemorrhagic | 5 (9%) | 8 (7%) | 14 (8%) | 27 (8%) | |
| Length of Stay in Days | 11.9 ± 6.3 | 13.7 ± 8.0 | 14.6 ± 7.4 | NS (p=.06) | 13.9 ± 7.4 |
| Charlson Comorbidity Index (median [range]) | 1 (0–8) | 1 (0–8) | 1 (0–9) | NS (p=.73) | 1 (0–9) |
| NIHSS | 4.8 ± 4.8 | 5.9 ± 5.3 | 8.4 ± 6.4 | Moderate > Mild (p=.001) and Normal (p<.001) | 7.0 ± 6.0 |
| Recurrent Stroke | 12 (22%) | 20 (18%) | 51 (30%) | p=.06 | 84 (25%) |
| First Stroke | 43 (78%) | 89 (82%) | 119 (70%) | 255 (75%) | |
| Admission Motor-FIM | 41.0 ± 12.6 | 35.8 ± 12.5 | 31.9 ± 13.4 | Normal > Mild (p=.04); Mild > Moderate (p=.04) | 34.7 ± 13.4 |
| Admission Cognitive-FIM | 30.2 ± 6.4 | 27.9 ± 5.8 | 23.7 ± 6.9 | Moderate < Mild (p<.001) and Normal (p<.001) | 26.2 ± 7.0 |
| Admission Total-FIM | 72.8 ± 17.9 | 65.2 ± 16.3 | 57.1 ± 18.4 | Normal > Mild (p=.03); Mild > Moderate (p=.001) | 62.3 ± 18.6 |
| Discharge Motor-FIM | 64.1 ± 10.8 | 55.4 ± 13.7 | 46.5 ± 15.9 | Normal > Mild (p=.001); Mild > Moderate (p<.001) | 52.3 ± 15.9 |
| Discharge Cognitive-FIM | 32.4 ± 2.8 | 30.1 ± 4.2 | 24.8 ± 6.5 | Normal > Mild (p<.001); Mild > Moderate (p<.001) | 27.8 ± 6.2 |
| Discharge Total-FIM | 98.8 ± 13.0 | 87.6 ± 15.9 | 73.0 ± 20.8 | Normal > Mild (p=.001); Mild > Moderate (p<.001) | 82.0 ± 20.7 |
| MoCA Total Score | 26.6 ± 1.6 | 21.9 ± 1.3 | 13.9 ± 4.0 | Normal > Mild (p<.001); Mild > Moderate (p<.001) | 18.6 ± 5.9 |
Notes. Values are Mean ± Standard Deviation, unless otherwise noted.